An example of this is a Karolinska Institute paper published in The Lancet in early 2006, which states donepezil improves cognitive function even in patients with severe AD symptoms.
Acetylcholinesterase inhibitors, such as donepezil, may be useful for Alzheimer disease and other similar diseases causing dementia such as Parkinsons or vascular dementia.